If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Pre-close Trading Update

9 Feb 2017 07:00

RNS Number : 3902W
TyraTech, Inc.
09 February 2017
 

 

 

Strictly embargoed until: 9 February 2017

 

TyraTech, Inc.

("TyraTech" or the "Company")

 

Pre-Close Trading Update

 

TyraTech, Inc. (AIM: TYR, and TYRU), a life sciences company focused on nature-derived insect and parasite control products, announces its pre-close trading update ahead of its Preliminary Results for the year ended 31 December 2016.

 

Market Overview and Financial Update

 

Despite a difficult market environment, gross sales of the Company's market leading Vamousse® head lice range of products continued to show double digit growth year on year, and the Vamousse brand gained market share against its major competitors.

 

The Company had indicated at the time of its Interim Results in September 2016, that the overall rate of growth of Vamousse had slowed in the second half of the year, mainly due to a deceleration of the lice category in the US, but the market did recover somewhat at the end of the year and finished almost flat in the US for the full year 2016.

 

In order to adapt to these market conditions, the Company has strictly controlled its overall level of expenses, and still expects the year end results to be broadly in line with current market forecasts and its cash position to be in excess of $1.7 m.

 

Business Update

 

Individual retail outlets across the distribution network in the US are now adding new Vamousse product Stock Keeping Units (SKUs), which is being driven by consumer demand. The Company is pleased that following CVS in the US in 2016, Walgreens, the biggest pharmaceutical chain with over 8,000 stores has also decided to add Vamousse Lice Defense shampoo and Vamousse Lice Elimination powder to Vamousse Treatment for the 2017 season.

 

After only being available online Guardian® (TyraTech's plant-based, non-toxic mosquito and tick repellent), will now be tested in Kroger stores, the biggest grocery chain in the US for the 2017 season.

 

In other initiatives, the Company has successfully finalized the development of its innovative, effective and non-toxic OutSmart™ Fly Spray repellent for the equine market. An additional patent filing has been made for the new formulation which was pre-launched by TyraTech's partner SmartPak at the end of 2016. The full launch for this product is expected during the second quarter of 2017 before the fly season begins.

 

The three animal health products sold under the brand PureScience™ are showing positive field testing results. Products have already been purchased and have received good feedback from several production facilities affiliated with the major poultry and swine producers in the US. Widespread adoption will take time, but reports from our partner MWI, the biggest distributor of animal health products in the US, show that the products are performing well.

 

Outlook, Strategic Direction and Date of Final Results

 

Taking into account the market conditions and these new product placements and adoptions, the Board is currently more cautious about revenue expectations but still anticipates double digit revenue growth in 2017. In addition, the Board continues to consider the strategic direction of the Company with respect to the personal care range of products including the Vamousse brand and the ultimately larger animal health opportunities.

 

The Company will announce Final Results for the year ended 31 December 2016 by the end of April 2017.

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

 

For further information:

 

TyraTech Inc.

Bruno Jactel, Chief Executive Officer

Erica H. Boisvert, Chief Financial Officer

www.tyratech.com

 

Tel: +1 919 415 4340

Tel: +1 919 415 4287

 

SPARK Advisory Partners Limited (Nominated Adviser)

Matt Davis / Mark Brady

 

 

 Tel: +44 20 3368 3551

 

Allenby Capital Limited (Broker)

Chris Crawford

 

 

Tel: +44 20 3328 5656

 

 

Belvedere Communications (PR)

John West / Kim van Beeck

 Tel: +44 20 3567 0510

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUWGPUPMGRR
Date   Source Headline
27th Apr 20129:59 amRNSAward of Share Options
20th Apr 20122:46 pmRNSHolding(s) in Company
18th Apr 20121:03 pmRNSHolding(s) in Company
10th Apr 20123:00 pmRNSDirector Dealing, Issue of Shares and AR Amendment
30th Mar 20122:36 pmRNSDirectorate Change
15th Mar 20125:00 pmRNSHolding(s) in Company
7th Mar 20122:04 pmRNSHolding(s) in Company
6th Mar 20127:00 amRNSIssue of Equity
5th Mar 20125:26 pmRNSHolding(s) in Company
2nd Mar 201211:42 amRNSHolding(s) in Company
27th Feb 20125:15 pmRNSResult of Special Meeting
17th Feb 201212:43 pmRNSAppointment of Joint Broker
14th Feb 20121:00 pmRNSProposed Placing and Subscription
2nd Feb 20129:00 amRNSTrading Update
1st Feb 20127:00 amRNSChange of Adviser
11th Jan 20127:00 amRNSTrading Update
7th Dec 201110:44 amRNSReplacement: Migration of Shares
7th Dec 20117:00 amRNSMigration of Shares and Block Listing Review
26th Oct 20117:00 amRNSCourt ruling in favour of TyraTech
25th Oct 20117:00 amRNSAdvisor appointed to seek Product Sale Partners
19th Oct 20117:00 amRNSTyraTech appoints a Head of European Operations
7th Oct 20117:00 amRNSMigration of shares
23rd Aug 20117:00 amRNSGerman Registrations for Three Aerosol Products
17th Aug 20117:00 amRNSDirector/PDMR Shareholding
11th Aug 20113:07 pmRNSDirector/PDMR Shareholding
11th Aug 20117:08 amRNSInterim Results
27th Jul 20115:38 pmRNSResult of AGM
30th Jun 20117:00 amRNSPosting of Annual Report and Accounts 2010
24th Jun 201112:01 pmRNSDirector/PDMR Shareholding
10th Jun 20115:55 pmRNSDirector/PDMR Shareholding
10th Jun 20115:46 pmRNSDirector/PDMR Shareholding
10th Jun 20117:00 amRNSPreliminary Results
7th Jun 20116:08 pmRNSDirector/PDMR Shareholding
1st Jun 20118:00 amRNSCourt ruling in favour of TyraTech
27th May 20114:56 pmRNSDirectorate Change
1st Mar 20118:00 amRNSShare migration to unrestricted trading line
25th Feb 20118:00 amRNSBlock listing application
4th Jan 20119:01 amRNSHolding(s) in Company
29th Dec 20102:23 pmRNSHolding(s) in Company
21st Dec 20102:26 pmRNSMajor Shareholdings
21st Dec 20109:00 amRNSIssue of Equity
30th Nov 20108:16 amRNSHolding(s) in Company
12th Nov 20103:31 pmRNSDirector Remuneration & Treasury Share Readmission
26th Oct 20102:59 pmRNSShare Migration to Unrestricted Trading Line
26th Oct 20102:59 pmRNSShare Migration to Unrestricted Trading Line
21st Oct 20103:22 pmRNSAward of Share Options
21st Oct 20103:22 pmRNSAward of Share Options
20th Oct 20107:00 amRNSSupply Agreement Signed With Terminix
6th Oct 20107:00 amRNSSignificant reorder from Terminix
4th Oct 20107:00 amRNSCorporate Broker Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.